Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.91% | -35.63% | -328.85% | -320.81% | 29.32% |
| Total Depreciation and Amortization | 4.70% | 1.47% | 4.30% | 2.23% | -4.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.30% | -59.57% | -119.37% | -115.26% | 99.96% |
| Change in Net Operating Assets | -- | -- | 188.02% | 186.37% | -- |
| Cash from Operations | -512.27% | -499.67% | 13.61% | 15.23% | 126.79% |
| Capital Expenditure | -12.50% | -12.50% | -418.18% | -409.09% | -60.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.50% | -12.50% | -418.18% | -409.09% | -60.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10,729.25% | -10,729.25% | 36.84% | 36.84% | 30.66% |
| Issuance of Common Stock | -97.29% | -97.29% | -100.00% | -100.00% | 22.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | -16.75% |
| Cash from Financing | -124.60% | -123.85% | -65.82% | -66.46% | 22.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -174.88% | -172.59% | -205.92% | -200.15% | 345.28% |